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There is growing awareness that prenatal adversity may increase the risk of autism spectrum 
disorder (ASD).  Here we examined the association between hypertensive disorders of 
pregnancy (HDP) and ASD risk at 7-years of age using the Millennium Cohort Study (MCS) 
a representative cohort of 13,192 children born in the UK from 2000-2001. We also sought to 
examine cytokine expression in the serum of women with the pre-eclampsia, which is the 
most common HDP, and whether exposure of fetal neurons to this serum could change 
patterns of neuronal growth.  HDP were reported by mothers nine months post-delivery. ASD 
was parent-reported at age seven, based on a doctor or health care professional’s diagnosis. 
Weighted logistic regression was used for data analysis, adjusting for several potential 
confounders including maternal alcohol consumption, education, depression, age, and 
poverty status. Sensitivity analyses were performed excluding pre-term births, small for 
gestational age (SGA), pre-pregnancy hypertension and depression. There was a significant 
association between HDP and a two-fold increased risk of ASD (AOR=2.10 [95% CI: 1.20-
3.70]). Excluding preterm excluding preterm births, SGA births and offspring of women who 
had pre-pregnancy hypertension or over the age of 40 did not change the results materially. 
At the cellular level, exposure of fetal cortical neurons to 3% serum isolated from women 
with an established HDP, increased neuronal growth and branching in vitro.  These findings 
indicate that HDP exposure may increase the risk of ASD in the offspring.  
 










Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that is characterised by 
deficits in socialisation, communication, and repetitive behaviour (Lai et al., 2014). There is 
also evidence for on-going central and peripheral immune dysregulation (Estes and 
McAllister, 2015), and dysregulation of the hypothalamic–pituitary–adrenal (HPA) stress 
response (Spratt et al., 2012). Recent evidence from 11 sites across the USA in the 
Autism and Developmental Disabilities Monitoring Network at the CDC, has reported that 
ASD affects 1 in 68 children (Christensen et al., 2016), and ASD is now a World Health 
Organisation global health priority. Although ASD is highly heritable with a strong genetic 
basis, increasing evidence suggests that non-genetic factors may play a role in its aetiology 
(Mandy and Lai, 2016; Sandin et al., 2014). Consequently there is an increasing focus on 
prenatal adversity as a potential risk factor for ASD (Mandy and Lai, 2016).  In addition a 
recent study has demonstrated focal patches of abnormal laminar cytoarchitecture and 
cortical disorganization of neurons, but not glia, in the prefrontal and temporal cortical tissue 
in children with ASD (Stoner et al., 2014).   This is suggestive of a potential dysregulation of 
brain development at prenatal developmental stages, as cortical lamination is on-going during 
the second trimester of pregnancy (Stiles and Jernigan, 2010). One of the most common 
forms of prenatal adversity that occur at this stage of pregnancy are hypertensive disorders of 
pregnancy (HDP). 
HDPs are the most common pregnancy complication, affecting 10-15% of 
pregnancies and they begin most frequently in the second trimester (Olson-Chen and 
Seligman, 2016).. HDP is an umbrella term for several hypertensive conditions of pregnancy, 
including gestational hypertension and pre-eclampsia (Olson-Chen and Seligman, 2016). 
Children with ASD are twice as likely to have been exposed in utero to pre-eclampsia 





2010) and maternal hypertension (Polo-Kantola et al., 2014) increase the risk of ASD in 
affected offspring.  In addition, brain structural alterations that share similarities with those 
seen in ASD have recently been described in non-affected children born of pregnancies 
complicated by pre-eclampsia (Ratsep et al., 2016). However, the impact of HDP on ASD 
risk requires further study in additional cohorts, and crucially the biological basis of the 
increased risk of ASD in affected offspring, which is unknown, requires further investigation. 
Here we sought to examine the association between HDPs and ASD in the 
Millennium Cohort Study, a cohort representative of children born in the UK in the year 2000 
(Connelly and Platt, 2014).  Recent studies have shown that dysregulation of circulating 
maternal cytokine signaling can lead to ASD-like behaviour in rodent offspring (Choi et al., 
2016) and increased levels of maternal cytokines and chemokines during gestation are 
associated with ASD with intellectual disability in humans (Jones et al., 2016). Moreover as 
placental IL-6 signalling is a crucial determinant of ASD-like behaviour (Wu et al., 2017), we 
also sought to determine if there were elevated cytokines in serum from women with 
established pre-eclampsia and whether exposure to maternal serum could alter patterns of 











2. Materials and Methods 
2.1 Cohort 
The Millennium Cohort Study (MCS) (Connelly and Platt, 2014), a nationally representative 
cohort of children born in the UK in the years 2000-2002, was used for epidemiological 
analysis. The MCS used a stratified cluster sampling design, stratified first by country within 
the UK (England, Scotland, Wales and Northern Ireland), then by electoral ward. Sampling 
methods have previously been described in detail (Plewis, 2007). Surveys of the MCS have 
been conducted in 5 waves: age 9 months (wave 1), age 3 years (wave 2), age 5 years (wave 
3), age 7 years (wave 4) and age 11 years (wave 5). For the current analysis, exposure and co-
variate information was collected from wave 1, and outcome information (ASD) was 
collected from wave 4. All variables were self-reported by the “main respondent” or “partner 
respondent.” Main respondents for the surveys were the infant’s biological mother the 
majority of the time (99.7%), partner respondents were the infant’s biological father the 
majority of the time (85.7%).  The London Multicentre Research Ethics Committee granted 
ethical approval for these surveys, and as the current investigation is a secondary data 
analysis no further approval was needed. All survey materials are available online 
(www.cls.ioe.ac.uk/mcs). 
2.2 Variables 
Hypertension during pregnancy (HDP) was measured at wave 1 using a two-tiered question. 
Women were first asked if they had suffered from any illnesses during pregnancy which 
required medical attention. Those that said “yes” were asked to choose from a list, including 
“raised blood pressure, eclampsia/pre-eclampsia or toxaemia.” Women who indicated this 
were considered cases of HDP. For ASD, parents were asked at wave 4 if a doctor or health 
professional had ever told them that their child had “autism, Asperger’s Syndrome, or ASD”. 





following problems?”).  Those that responded “yes” were considered to have ASD and were 
considered cases for the analysis. The data from this wave of the MCS have previously been 
used to examine the factors impacting ASD (Curran et al., 2016; Russell et al., 2014), and all 
survey materials are available online (www.cls.ioe.ac.uk/mcs). Other variables that were 
considered were smoking during pregnancy, gestational age at birth, small for gestational age 
(SGA) (calculated using a customised centile calculator (Gardosi and Francis, 2013), poverty, 
ethnicity, urbanicity, sex, birth order, and maternal age, education, depression, body mass 
index (BMI) (as defined by the World Health Organisation), pregestational diabetes and 
pregestational hypertension. Variables were categorised as shown in Table 1. 
2.3 Statistical analysis 
Logistic regression models were used to examine the association between HDP and reported 
ASD. Crude analysis was conducted, followed by adjustment for smoking during pregnancy, 
birth order, and poverty, as well as maternal ethnicity, age, education, depression, BMI, 
pregestational diabetes and pregestational hypertension. Crude and adjusted analyses were 
also conducted on several sub-groups: women without pregestational hypertension, women 
under the age of 40 at birth, babies that were not born pre-term, and babies that were not born 
SGA. Analysis was then stratified by sex and birth order. To account for the complex 
sampling design employed in the MCS, analyses were weighted and survey commands were 
used in SAS. As weights have been previously shown not to be significantly changed 
between waves (Plewis, 2007), wave 1 weights were used. All analysis was done using SAS 
version 9.4. 
2.4 Multiplex ELISA measurements 
Multiplex cytokine analysis was performed on time of disease serum samples from five 
women with severe term pre-eclampsia from the screening of pregnancy endpoints (SCOPE) 





2014).  Five control non-pre-eclampsia samples were from nulliparous women with singleton 
pregnancies that were randomly selected matched for age and BMI. Ethical approval was 
obtained from the local ethics committee (Cork. ECM5 (10) 05/02/08) and all women 
provided written informed consent. Serum cytokines and chemokines were measured using a 
Human multi-Plex Ultra-Sensitive kit (MSD Gaithersburg, MD) in a 96-well format. Each 
well of each 96-well plate was coated with capture-antibodies to Eotaxin1, MCP-1, IFN-, L-
6, IL-8 and the assay was run according the manufacturer’s recommended protocol. Cytokine 
concentrations were determined using MSD Discovery Workbench Software (v. 3.0.17). All 
data were analysed using a Students t-test and considered significant when p < 0.05. 
2.5 Primary neuron culture and analysis   
Embryonic day (E) 18 Sprague-Dawley rat embryos were removed by laparotomy and 
transferred to ice-cold Hank’s Balanced Salt Solution (Sigma). Primary cultures of cortical 
neurons were prepared as previously described (Hegarty et al., 2014).  2x105 cells were 
electroporated with 0.5g of an enhanced GFP expression plasmid using the NeonTM 
Transfection System (Invitrogen) according to the manufacturer’s protocol under specific 
parameters (1100 V; 30 ms; 2 pulses). Dissociated neurons were plated on poly-D-lysine-
coated 24-well plates at a density of 1x105 cells per well in DMEM/F12, 33 mM D-glucose, 
1% L-glutamine, 1% FCS, 2% B27. Cultures were incubated in a humidified atmosphere 
containing 5% CO2 at 37°C.  After 24 h, cultures were treated with 3% serum from patients 
with pre-eclampsia (n=5) or matched controls (n=5) from the SCOPE study (Kenny et al., 
2014).  Sera-treated, GFP-positive cortical neurons were imaged with an (Olympus IX70) 
inverted microscope fitted with an Olympus DP70 camera and AnalysisDTM software 24 h 
later.  Neurite growth analysis was performed in a blinded fashion as previously described 
(Gutierrez and Davies, 2007; O'Keeffe et al., 2016). All data were analysed using a Students 






3.1 Millennium Cohort Study 
There were 18,296 singleton babies that participated in the wave 1 survey. Of these, 13,192 
participated in the wave 4 survey, and 13,098 had data on both HDP and ASD. Of the 13,098 
children that were included in analysis, 983 (7.50%) were exposed to HDP. There were 199 
(1.52%) reported cases of ASD, 30 (3.05%) of which were exposed to HDP (Table 1). In 
unadjusted analysis, the OR of the association between HDP and ASD was 2.27 (95% CI = 
1.43-3.60), this was not materially changed after adjustment (AOR = 2.10; 95% CI = 1.20-
3.70) (Table 2). When women over the age of 40 were excluded, the association appeared 
slightly stronger (AOR = 2.63; 95% CI = 1.27-4.02), but this was not a significant change 
(chi-square for heterogeneity p = 0.74). No other sub-groups (e.g. women without 
pregestational hypertension, babies that were not pre-term and babies that were not SGA) 
were different from the main cohort results (Table 2). Stratification by sex did not have an 
impact on results (Table 2). When the cohort was stratified by birth order, the association 
appeared weaker in children that were first born (OR = 2.08; 95% CI = 1.10-3.95), compared 
to children born second or more (OR = 2.49; 95% CI = 1.27-4.87) but this was not 
statistically significant (p = 0.70). 
3.2 Cytokine and chemokine levels in women with established pre-eclampsia. 
We next examined the expression of Eotaxin1, MCP-1, IFN-, IL-1, L-6 and IL-8 (Masi et 
al., 2015) in the serum of women with established pre-eclampsia which is one of the more 
common hypertensive disorders, in the SCOPE cohort. Multiplex ELISA analysed revealed 
no statistically significant differences between Eotaxin1, MCP-1, IFN-and IL-8 (IL-1 was 
not detectable) between cases and controls, however there was a trend towards an increase in 
IL-6 (t(8) = 2.18, p=0.06) (Fig. 1). Given the detailed maternal data available in the SCOPE 





matched controls, and in four out of 5 cases the level of  IL-6  was higher than in their 
matched control (Table 3). 
3.3 Serum from patients with pre-eclampsia promotes excessive neuronal growth.   
As aberrant connectivity is a core feature of ASD, we next sought to determine if there were 
circulating factors present in maternal sera that could affect fetal neuron growth, E18 cortical 
neurons were transfected with GFP to visualise the neuronal arbors and plated for 24h.  
Cultures were then treated with 3% serum from patients with term pre-eclampsia (P) (≥ 37 
weeks) or matched controls (C) for 24h.  Treatment with serum from patients with pre-
eclampsia significantly increased the number of neurites, total neurite length (C: 272±17µm v 
P: 372±19µm; t(8)=3.6; p=0.007) (Fig. 2a), (C: 1.8±0.1 v P: 2.4±0.2; t(8)=4.3; p=0.003) (Fig. 
2b), and branching (C: 2.5±0.3 v P: 3.9±0.2; t(8)=4.1; p=0.004) (Fig. 2c), when compared to 
neurons treated with serum from matched controls (Fig. 2d).   
 
4. Discussion 
This study examined the impact of hypertension during pregnancy on ASD, using 
epidemiological analysis on data from the MCS cohort. In the MCS cohort, a cohort 
representative of children born in the UK in the year 2000, children exposed to HDP were 
over twice as likely to be diagnosed with ASD by age 7. This association remained consistent 
after adjustment for several variables and across various sub-groups of the population.  
In agreement with our data, a number of studies have reported an increased risk of 
ASD in offspring exposed to a HDP. For example, Buchmayer et al. carried out a case-
control study which reported that pre-eclampsia exposure lead to a greater than 50% increase 
in the risk of ASD in the offspring (Buchmayer et al., 2009). A significant association 
between pre-eclampsia and ASD was also seen by Burstyn et al. in a study cohort of 218,890 





who reported that there was a marginally increased risk for ASD among offspring to mothers 
with pregnancy-induced hypertension (Hultman et al., 2002). In agreement with these earlier 
findings, a number of more recent studies have also specifically examined the association 
between HDP exposure and ASD risk in the offspring.  Langridge et al. examined maternal 
conditions and perinatal factors for children diagnosed with ASD with or without intellectual 
disability, and reported that pregnancy hypertension, which was defined as pre-eclampsia or 
essential hypertension, was associated with an increased risk of ASD with intellectual 
disability (Langridge et al., 2013). Some studies have also specifically examined the 
association between pre-eclampsia (the most common HDP) and ASD. Mann et al. in a study 
of 87,677 births reported a significant association between pre-eclampsia and ASD risk 
whether or not birth weight was controlled for (Mann et al., 2010). In agreement with this, 
Walker et al. reported that children with ASD were twice as likely to have been exposed in 
utero to pre-eclampsia when compared to controls, even after adjustment for a number of 
potential confounders including maternal education, parity and pre-pregnancy obesity 
(Walker et al., 2015).   
However it should be noted that in contrast to our present report, other studies that 
have examined the impact of pre-eclampsia on ASD risk, have reported no association 
(Glasson et al., 2004; Larsson et al., 2005). In addition to this, data from the CHARGE study 
(Childhood autism Risks from Genetics and the Environment), which was a population-
based, case-control investigation, has shown that although the prevalence of pre-gestational 
hypertension was more common among ASD case mothers than controls, once covariate 
adjustment was made this association was not significant (Krakowiak et al., 2012). Moreover 
similar data were found by Lyall et al, who reported that pregnancy-related high blood 
pressure had no association with ASD in the offspring (Lyall et al., 2012). These findings are 





induced hypertension and ASD in the offspring (Bilder et al., 2009; Dodds et al., 2011). 
These reports emphasise the significant variations in relation to whether HDP exposure 
increases the risk of ASD in affected offspring, and highlight the need for a systematic review 
and meta-analysis to identify if possible an overall pooled estimate of association (Maher et 
al., 2017). This also raises the issue of why there is a significant heterogeneity between 
studies. It is worth noting that previous studies reporting an association between pre-
eclampsia, the most common HDP, and ASD have reported that the risk increased with 
greater pre-eclampsia severity (Walker et al., 2015).  This suggests that the severity of the 
HDP may be a crucial factor in determining the impact on neurodevelopmental outcome. For 
example, pre-eclampsia may have a stronger impact on development of ASD than 
hypertension alone, which may help to explain different findings across studies examining 
sub-types of HDPs. Although in the MCS cohort we were unable to examine the association 
by sub-type of HDP, however this may be of interest in future research. 
 In this study we also showed that exposure of fetal cortical neurons to serum from 
women with pre-eclampsia lead to increased neurite growth.  It is important to stress that this 
does not imply causation with regards to ASD risk, but rather that there is the potential for a 
circulating factor(s) present in maternal serum as a result of pre-eclampsia that can change 
patterns of fetal neuronal growth.  In future work it will be important to determine whether 
this happens in vivo, whether this leads to ASD-like behavioural changes in affected 
offspring, and to identify the factor or factors that leads to these changes.  It is however 
interesting to note that it has recently been shown that elevations in maternal IL-17a leads to 
an abnormal cortical phenotype and behavioural disturbances in affected offspring (Choi et 
al., 2016).  Given that there is an increase in circulating IL-17a in PE (Darmochwal-Kolarz et 
al., 2012; Toldi et al., 2011), disturbances in the maternal immune system in HDP may be a 





note that it has recently been shown that elevated IL-6 signalling in the placenta is necessary 
and sufficient for the development of ASD-like social deficits in exposed offspring (Wu et 
al., 2017). Given that we found that 4 of 5 pre-eclampsia samples had elevated levels of IL-6 
compared to a matched control, it is possible that in some cases of pre-eclampsia, elevated 
placental IL-6 signalling may relay inflammatory signals to the fetal brain to impact neuronal 
development. 
This study has several strengths. It utilised a large, contemporary, population-based 
cohort. Due to the sampling method employed in the MCS, the cohort is representative of 
children born in the UK in the years 2000-2001. However, this study is also subject to some 
limitations. Firstly, in the MCS, data were reported by parents. As the cohort is anonymised, 
it was not possible to validate reported HDP or ASD, and these may have been mis-reported. 
The first survey was conducted 9 months after birth, and exposure variables may have been 
subject to some recall bias, though HDP has been previously shown to be accurately reported 
post-delivery (Falkegard et al., 2015). Similarly, in the wave 4 survey, the wording of the 
question on ASD (e.g. “has a doctor or health professional ever told you…”) may have been 
overly inclusive, as parents may have reported cases that were suspected but not confirmed 
by doctors. However, previous publications have used the MCS to examine ASD (Curran et 
al., 2016; Russell et al., 2014) and ADHD (Bohm et al., 2017) in the UK. Also, HDP was 
reported overall, and could not be examined by sub-group or severity. Previous results 
indicate that the association between pre-eclampsia and ASD may depend on severity 
(Walker et al., 2015) and future work should investigate this association further by examining 
the effect of sub-group on ASD risk. 
The findings of this study suggest that children exposed to HDP are more likely to 





women with pre-eclampsia may lead to changes in neuronal growth, but further in vivo 
studies are needed to determine what effect this may have on the development of ASD. 
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Table 1. Maternal and Neonatal Characteristics of the Millennium Cohort Study by 






Maternal age    
14 to 19 years 904 (7.46) 76 (7.73) 
20 to 29 years 5451 (44.99) 469 (47.71) 
30 to 39 years 5481 (45.24) 416 (42.32) 
40+ years 268 (2.21) 76 (7.73) 
Missing 11 (0.09) 0 (0.00) 
White Ethnicity 10319 (85.18) 881 (89.62) 
Urbanicity   
Urban 8021 (66.21) 655 (66.63) 
Suburban 747 (6.17) 77 (7.83) 
Rural 621 (5.13) 51 (5.19) 
Missing 2726 (22.50) 200 (20.35) 
Maternal education   
Secondary school 6468 (53.39) 572 (58.19) 
Higher degree 3561 (29.39) 295 (30.01) 
No degree 1423 (11.75) 82 (8.34) 
Missing 663 (5.47) 34 (3.46) 
Poverty (income  under 60% OECD national  
median)    
Yes 4035 (33.31) 270 (27.47) 
No 8044 (66.40) 713 (72.53) 
Missing 36 (0.30) 0 (0.00) 
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Maternal BMI   
Normal weight 7523 (62.10) 482 (49.03) 
Underweight 643 (5.31) 30 (3.05) 
Overweight 2272 (18.75) 258 (26.25) 
Obese 936 (7.73) 161 (16.38) 
Missing 741 (6.12) 52 (5.29) 
Smoking during pregnancy   
Never 8049 (66.44) 698 (71.01) 
Quit 1408 (11.62) 129 (13.12) 
Light 1430 (11.80) 97 (9.87) 
Heavy 1208 (9.97) 58 (5.90) 
Missing 20 (0.17) 1 (0.10) 
Maternal depression   
Not Depressed 9193 (75.88) 683 (69.48) 
Depressed, not treated 1855 (15.31) 183 (18.82) 
Depressed, treated 1043 (8.61) 114 (11.60) 
Missing 24 (0.20) 1 (0.10) 
Diabetes unrelated to pregnancy 51 (0.42) 20 (2.03) 
Longstanding Hypertension   
Yes 20 (0.17) 47 (4.78) 
No 12081 (99.72) 936 (95.22) 
Missing 14 (0.12) 0 (0.00) 
 








Sex (Male) 6126 (50.57) 513 (52.19) 
First born 4942 (40.79) 531 (54.02) 
Small for gestational age (centile <10) 1861 (15.36) 218 (22.18) 
Gestational age at birth   
40 weeks 3476 (28.69) 222 (22.58) 
24-36 weeks 703 (5.80) 155 (15.77) 
37 weeks 631 (5.21) 69 (7.02) 
38 weeks 1588 (13.11) 163 (16.58) 
39 weeks 2547 (21.02) 201 (20.45) 
41+ weeks 3026 (24.98) 165 (16.79) 




Table 2. The association between hypertension during pregnancy and autism spectrum 
disorder in the Millennium Cohort Study 
  
                      Exposed  
                         cases 
    Adjusted*OR 
    (95% CI) 
Hypertension during pregnancy and ASD                              30                        2.10 (1.20-3.70) 
Excluding women with longstanding hypertension 27 2.02 (1.12-3.63) 
Excluding women aged 40+ 30 2.63 (1.27-4.02) 
Excluding pre-term babies 27 2.11 (1.15-3.88) 
Excluding small for gestational age babies 22 2.37 (1.28-4.39) 
Excluding women with longstanding 
hypertension 
          27 2.02 (1.12-3.63) 
Excluding women aged 40+ 30 2.63 (1.27-4.02) 
Excluding pre-term babies 27 2.11 (1.15-3.88) 
Excluding small for gestational age 
babies 
22 2.37 (1.28-4.39) 
Among girls  7 2.29 (0.88-6.00) 
Among boys 23 2.18 (1.29-3.66) 
Among first born 17 2.08 (1.10-3.95) 
Among birth order 2+ 13 2.49 (1.27-4.87) 
*Adjusted for: smoking during pregnancy, birth order, and poverty, as well as maternal ethnicity, age, 
education, depression, BMI, longstanding diabetes and longstanding hypertension 





Table 3. IL-6 levels in matched case-control pairs 
Control-Case   Control         Case 
Matched pair 1  0.26pg/ml 1.69pg/ml 
Matched pair 2  0.78pg/ml 0.41pg/ml 
Matched pair 3  0.47pg/ml 1.08pg/ml 
Matched pair 4  0.32pg/ml 0.55pg/ml 



















Figure 2. Pre-eclampsia serum promotes neurite growth in fetal cortical neurons.  
Bar charts showing (a) total neurite length, (b) number of neurite per soma, (c) neurite 
branching and (d) representative photomicrographs of GFP-positive E18 cortical neurons 
cultured for 24 h with 3% serum from patients with term pre-eclampsia or matched controls.  
Mean ± SEM of data from 75 neurons in each condition from 5 individual serum samples.  
*** P < 0.001, statistical comparison with control; Student’s t-test. Scale bar = 50µm. 
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